Efficacy of orally administered fluralaner (Bravecto(TM)) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs

BACKGROUND: This laboratory study compared the efficacy of Bravecto™ (fluralaner), formulated as a chewable tablet, with the efficacy of Advocate® (imidacloprid/moxidectin), formulated for topical administration, against naturally acquired generalized demodicosis in dogs. METHODS: Sixteen dogs, all...

Descripción completa

Detalles Bibliográficos
Autores principales: Fourie, Josephus J, Liebenberg, Julian E, Horak, Ivan G, Taenzler, Janina, Heckeroth, Anja R, Frénais, Regis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394402/
https://www.ncbi.nlm.nih.gov/pubmed/25881320
http://dx.doi.org/10.1186/s13071-015-0775-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394402/
https://www.ncbi.nlm.nih.gov/pubmed/25881320
http://dx.doi.org/10.1186/s13071-015-0775-8

Ejemplares similares